Dana Weir is of counsel in the Patent Litigation practice of Paul Hastings and is based in the firm's New York office. Ms. Weir's practice primarily focuses on complex litigation in the chemical, pharmaceutical, and biotechnology areas.
Ms. Weir has extensive experience in patent litigation and counseling in a broad range of technologies. She has experience in all stages of major patent litigation, including pre-suit investigations, discovery, trial, post-trial and appeal. Ms. Weir has represented innovative brand name pharmaceutical companies in complex Hatch-Waxman litigations against multiple defendants, as well as biotech and electronics companies.
Ms. Weir received her J.D. from New York University in 2005, where she was an Articles Editor for the Annual Survey of American Law. Ms. Weir performed graduate research and completed coursework in Biological Psychology at the University of Illinois at Urbana Champaign. She earned a B.A. in Chemistry from Columbia University in 2000. Ms. Weir is a member of the State Bar of New York. She is also admitted to practice before the United States Patent and Trademark Office and the United States District Courts for the Southern and Eastern Districts of New York.
Takeaways from Paul Hastings’ Completion of the First Zoom Hatch-Waxman Act Trial in DNJ
October 07, 2020
FDA “Supercharges” Paragraph IV Certifications List, Adding to Its Usefulness as a Resource
July 25, 2019
Generic Found to Infringe Valid Patent Claims Covering Helsinn’s Aloxi® Product
February 21, 2017
District of New Jersey Amends Local Patent Rules
February 07, 2017
Nominated for the Legal Media Group's LMG Life Science Awards
The firm was nominated for the Legal Media Group's 2013 LMG Life Sciences awards in the categories of “Litigation Team of the Year” and “(General) Patent Litigation: Firm of the Year."
August 12, 2013